Agios Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, today announced that preclinical data from Agios’ research in cancer metabolism will be highlighted in a major symposium at the American Association for Cancer Research (AACR) Annual Meeting 2013 taking place April 6-10, 2013 in Washington, DC.
